Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences. (8th November 2015)
- Record Type:
- Journal Article
- Title:
- Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences. (8th November 2015)
- Main Title:
- Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences
- Authors:
- Blanco, Rancés
Domínguez, Elizabeth
Morales, Orlando
Blanco, Damián
Martínez, Darel
Rengifo, Charles E.
Viada, Carmen
Cedeño, Mercedes
Rengifo, Enrique
Carr, Adriana - Other Names:
- Volante Marco Academic Editor.
- Abstract:
- Abstract : The prognostic role of N-glycolyl GM3 ganglioside (NeuGcGM3) expression in non-small cell lung carcinoma (NSCLC) still remains controversial. In this study, the NeuGcGM3 expression was reevaluated using an increased number of NSCLC cases and the 14F7 Mab (a highly specific IgG1 raised against NeuGcGM3). An immunohistochemical score integrating the percentage of 14F7-positive cells and the intensity of reaction was applied to reassess the relationship between NeuGcGM3 expression, some clinicopathological features, and the overall survival (OS) of NSCLC patients. The double and the triple expression of NeuGcGM3 with the epidermal growth factor receptor (EGFR) and/or its ligand, the epidermal growth factor (EGF), were also evaluated. NeuGcGM3 expression correlates with both S-Phase fraction (p = 0.006 ) and proliferation index (p = 0.000 ). Additionally, NeuGcGM3 expression was associated with a poor OS of patients in both univariate (p = 0.020 ) and multivariate (p = 0.010 ) analysis. Moreover, the double and/or the triple positivity of tumors to NeuGcGM3, EGFR, and/or EGF permitted us to identify phenotypes of NSCLC with a more aggressive biological behavior. Our results are in agreement with the negative prognostic significance of NeuGcGM3 expression in NSCLC patients. However, standardization of techniques to determine the expression of NeuGcGM3 in NSCLC as well as the implementation of a universal scoring system is recommended.
- Is Part Of:
- Pathology research international. Volume 2015(2015)
- Journal:
- Pathology research international
- Issue:
- Volume 2015(2015)
- Issue Display:
- Volume 2015, Issue 2015 (2015)
- Year:
- 2015
- Volume:
- 2015
- Issue:
- 2015
- Issue Sort Value:
- 2015-2015-2015-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-11-08
- Subjects:
- Pathology -- Periodicals
571.905 - Journal URLs:
- https://www.hindawi.com/journals/pri/ ↗
- DOI:
- 10.1155/2015/132326 ↗
- Languages:
- English
- ISSNs:
- 2090-8091
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 10658.xml